Danuta Gray Acquires 750 Shares of Croda International (LON:CRDA) Stock

Croda International Plc (LON:CRDA) insider Danuta Gray bought 750 shares of the business’s stock in a transaction that occurred on Friday, March 6th. The stock was purchased at an average price of GBX 2,788 per share, with a total value of £20,910.

Croda International Stock Performance

LON CRDA traded down GBX 45 during trading on Friday, reaching GBX 2,794. 911,974 shares of the company’s stock were exchanged, compared to its average volume of 3,964,642. The company has a debt-to-equity ratio of 34.76, a current ratio of 1.99 and a quick ratio of 2.25. The business has a 50 day moving average price of GBX 2,851.94 and a 200-day moving average price of GBX 2,759.74. The stock has a market capitalization of £3.90 billion, a P/E ratio of 18.14, a PEG ratio of 1.40 and a beta of 0.93. Croda International Plc has a fifty-two week low of GBX 2,426.77 and a fifty-two week high of GBX 3,324.

Croda International (LON:CRDA) last released its quarterly earnings data on Tuesday, February 24th. The company reported GBX 146.20 earnings per share (EPS) for the quarter. Croda International had a return on equity of 2.82% and a net margin of 3.65%. Sell-side analysts forecast that Croda International Plc will post 181.8307268 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group downgraded shares of Croda International to a “hold” rating and decreased their price objective for the company from GBX 3,100 to GBX 3,000 in a report on Tuesday, November 11th. Two equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, Croda International has a consensus rating of “Hold” and an average price target of GBX 3,112.50.

About Croda International

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.